[ad_1]
Researchers at the University of Hong Kong have found that an affordable antimicrobial used to treat stomach ulcers and bacterial infections is effective in fighting COVID-19, according to MedicalXpress, cited by BGNES.
It is ranitidine bismuth citrate (RBC), which has been tested on hamsters.
As a result of the experiment, the viral load in the lung cells of infected rodents was reduced by more than 1000 times. In addition, the drug significantly reduced the level of the main anti-inflammatory cytokines and chemokines in the event of a severe course of COVID-19.
The researchers noted that red blood cells have low cytotoxicity with a high selectivity index, suggesting their safety compared to remdesivir, the other potential drug against coronavirus.
China
[ad_2]
